Patents by Inventor Yotam LIOR

Yotam LIOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALPHA-1-ANTITRYPSIN MUTANTS, COMPOSITIONS COMPRISING SAME, AND USE THEREOF
    Publication number: 20230068487
    Abstract: The present invention includes mutants of human alpha-1-antitrypsin (mhAAT). Further provided are compositions including the mhAAT and use of same, such as for modulating an immune cell, and treating a condition, such as inflammation.
    Type: Application
    Filed: January 28, 2021
    Publication date: March 2, 2023
    Inventors: Yotam LIOR, Eli Chaim LEWIS
  • Mutant alpha-1-antitrypsin compositions and use thereof
    Patent number: 11492390
    Abstract: The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: November 8, 2022
    Assignee: B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Eli Chaim Lewis, Yotam Lior
  • MUTANT ALPHA-1-ANTITRYPSIN COMPOSITIONS AND USE THEREOF
    Publication number: 20200140524
    Abstract: The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
    Type: Application
    Filed: April 2, 2018
    Publication date: May 7, 2020
    Inventors: Eli Chaim LEWIS, Yotam LIOR